Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, and Immune Cell Function and Interaction.
Guidelines for T cell nomenclature
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors
Single-cell analysis of regions of interest (SCARI) using a photosensitive tag
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Trastuzumab emtansine (T-DM1) renders HER2 <sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade